Haven't used Ophtalmopharma yet?
Ask AI

Ask AI about Ophtalmopharma

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="ophthalmopharma-com" data-lang="en"></div>
More widgets

About Ophtalmopharma

OphthalmoPharma (OPPH) is a pharmaceutical company specializing in the development of ophthalmology treatments. Their product pipeline addresses major unmet medical needs including dry eye syndrome, glaucoma, and age-related macular degeneration (AMD).

Ophthalmopharma has granted Altacor exclusive rights for its two proprietary therapeutic products for the treatment of glaucoma and dry eye as well as exclusive rights for its EyeBar, a nutraceutical for the prevention of dry AMD and the preloaded injector for delivery of intraocular lens in cataract and corrective lens replacement surgery (currently known as SOLO).